Drug intelligence / Profile preview

Polypill V2

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

A polypill is a single pill combining multiple medications, typically used for the prevention and treatment of chronic conditions, most notably cardiovascular diseases. The concept aims to improve patient adherence by simplifying medication regimens. Different formulations of polypills exist, often including combinations of aspirin, statins, and various blood pressure-lowering drugs. The "V2" likely indicates a specific version or formulation within a research or development context, but its exact composition is not publicly defined.

Beyond the preview

Go deeper on Polypill V2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polypill V2.

Explore the full profile